You are here: Industry Insights > vaccines

News List

Touchlight to Supply GMP dbDNA to Support University of Nottingham’s Clinical Study for a Next-Generation Vaccine for Zika Virus Biotech Newswire
August 22, 2024
Touchlight announced the clinical supply of its proprietary dbDNA? to the University of Nottingham for research and development of a next-generation DNA vaccine targeting the Zika virus.
Touchlight and GSK Sign License Agreement for Use of Enzymatic dbDNA Production Technology for mRNA Manufacturing Biotech Newswire
July 24, 2024
Touchlight announced a license agreement with GSK, a global leader in biopharmaceutical innovation.
Viroclinics-DDL Changes Name to Cerba Research PharmaSources
March 15, 2024
Viroclinics-DDL proudly announces changing its name to Cerba Research as of the 1st of April 2024.
Sartorius Forms Partnership with SPARTA Biodiscovery on Novel Nanoparticle Analysis Platform B3C newswire
November 06, 2023
The life science group Sartorius and UK-based startup SPARTA Biodiscovery have agreed to partner on SPARTA’s analysis platform.
serYmun Yeast Announces Preclinical Safety and Efficacy Data for Their Yeast-Based Vaccine Against Porcine Parvovirus (PPV) PharmaSources
March 06, 2023
an animal health vaccine development company based in Germany, announces the breakthrough in the development of their first pig vaccine candidate against porcine parvovirus.
ReiThera and Exothera Collaborate to Develop Large-scale, Low Cost per Dose Manufacturing Process to Deliver Novel Vaccines to Low- and Middle-Income Countries PharmaSources.com
April 12, 2022
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
Could COVID-19 vaccines be swallowed? EuropeanPharmaceuticalReview
February 10, 2022
New pre-clinical research demonstrates the potential of gastric autoinjectors to deliver mRNA in sufficient quantities for vaccination.
Coriolis Pharma Opens New ATMP Formulation Development Facilities B3Cnewswire
February 07, 2022
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of biopharmaceuticals and vaccines...
DCGI approves “Conditional Market Authorisation” of Covaxin and Covishield ExpressPharma
January 28, 2022
The approval pathways through this route are fast-tracked with certain conditions to enhance the access to certain pharmaceuticals for meeting the emerging needs of drugs or vaccines
Air of optimism surrounds lung cancer vaccine pharmatimes
January 18, 2022
Cancer Research UK announces clinical trial for most common type of lung cancer